Business Description
Cybin Inc
NAICS : 541714
SIC : 3741
ISIN : CA23256X1006
Share Class Description:
CYBN: Ordinary SharesCompare
Compare
Traded in other countries / regions
CYBN.USACYBN.CanadaR7E1.Germany IPO Date
2020-11-10Description
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 106.56 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.42 | |||||
| 9-Day RSI | 32.2 | |||||
| 14-Day RSI | 38.07 | |||||
| 6-1 Month Momentum % | -22.12 | |||||
| 12-1 Month Momentum % | 37.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.76 | |||||
| Quick Ratio | 5.76 | |||||
| Cash Ratio | 4.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -19.68 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -112.24 | |||||
| ROA % | -101.33 | |||||
| ROIC % | -161.03 | |||||
| ROC (Joel Greenblatt) % | -4100.84 | |||||
| ROCE % | -107.27 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.52 | |||||
| Price-to-Tangible-Book | 4.38 | |||||
| EV-to-EBIT | -4.53 | |||||
| EV-to-EBITDA | -4.56 | |||||
| EV-to-Forward-EBITDA | -5.44 | |||||
| EV-to-FCF | -5.2 | |||||
| Price-to-Net-Current-Asset-Value | 4.38 | |||||
| Price-to-Net-Cash | 5.83 | |||||
| Earnings Yield (Greenblatt) % | -22.08 | |||||
| FCF Yield % | -17.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:CYBN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cybin Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.208 | ||
| Beta | 0.78 | ||
| Volatility % | 102.05 | ||
| 14-Day RSI | 38.07 | ||
| 14-Day ATR ($) | 0.024277 | ||
| 20-Day SMA ($) | 0.38909 | ||
| 12-1 Month Momentum % | 37.08 | ||
| 52-Week Range ($) | 0.21 - 0.738 | ||
| Shares Outstanding (Mil) | 759.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cybin Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cybin Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cybin Inc Frequently Asked Questions
What is Cybin Inc(CYBN)'s stock price today?
The current price of CYBN is $0.35. The 52 week high of CYBN is $0.74 and 52 week low is $0.21.
When is next earnings date of Cybin Inc(CYBN)?
The next earnings date of Cybin Inc(CYBN) is 2024-06-27 Est..
Does Cybin Inc(CYBN) pay dividends? If so, how much?
Cybin Inc(CYBN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers